It works within your bodys existing feedback systems, allowing the hypothalamus and pituitary to regulate GH output naturally
Instead, the selected literature was analyzed and synthesized thematically, with studies grouped according to biological pathways (e.g., monoaminergic modulation, neurotrophic signaling, HPA-axis regulation, neuroinflammation, oxidative stress, and mitochondrial function) and level of evidence (preclinical versus clinical)
KLOW is a four-peptide research blend containing BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg) and KPV (10mg)
Sign up for the Bodywork newsletter.
In 2016, Alize Pharma achieved positive results in a Phase II trial with AZP-531 , a first-in-class unacylated ghrelin peptide analog, but was unable to advance the treatment further